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Available online 14 January 2016Hermansky–Pudlak syndrome (HPS) is a rare autosomal recessive disorder characterized by deﬁciencies in
lysosome-related organelles such as melanosomes and platelet-dense granules. The disorder is classiﬁed into
nine different subtypes (HPS1–HPS9) based on genetic mutations in 9 unique genes. Here we describe the
generation of an HPS1 iPSC line (CHOPHPS1) using a Cre-excisable polycistronic STEMCCA lentivirus. This line
was derived from human ﬁbroblasts isolated from a patient carrying a duplicative mutation in the HPS1 gene.
The patient presented with oculocutaneous albinism, early pulmonary ﬁbrosis, and hemorrhagic diathesis.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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nk to related literature Oh et al., 1996
formation in public databases N/AInResource details
Human skin ﬁbroblasts isolated from a 26 year old Puerto Rican
female HPS1 patient were obtained from the Coriell Cell Repositories
(Camden, NJ). The parental line, GM14609, carries a homozygous
16 bp duplication (codons 491–496) in exon 15 of the HPS1 gene. The
cellswere transducedwith STEMCCACre-excisable constitutive polycis-
tronic lentivirus expressing Oct4, Klf4, Sox2, and c-myc. Cre-mediatedMolecular Therapeutics, The
. This is an open access article underexcision of the vector following reprogramming was demonstrated
(Fig. 1A). Themutationwas validated by DNA sequencing and quantita-
tive PCR (qPCR) (Fig. 1B). The cells exhibited a normal karyotype (46,
XX) upon G-band analysis (Fig. 1C).
Pluripotency was veriﬁed by gene expression of stem cell markers
DMNT3B, REX1, ABCG2, OCT4, NANOG, and SOX2 using qPCR (Fig. 1E).
In addition, expression of pluripotent surface markers at single cell
resolution was conﬁrmed by ﬂow cytometry (Fig. 1D). Differentiation
capacity into three germ layers was conﬁrmed by in vivo teratoma
formation (Fig. 1F).
Materials and methods
Cell culture and iPSC reprogramming
Human HPS1 ﬁbroblast line, GM14609, was cultured in IMDM
(Mediatech) containing 10% FBS at 37 °C and 5% CO2 in a humidiﬁed
incubator. STEMCCA lentiviral vector was produced, and cells were
infected as previously described (Somers et al., 2010). The STEMCCA
Cre-Excisable Constitutive Polycistronic viral vector used for
reprogramming encoded Oct4, Klf4, Sox2, and c-myc. Human ﬁbro-
blasts were incubated with (5–10 μl) STEMCCA virus plus 5 μg/ml of
polybrene in ﬁbroblast medium. Six days after infection, cells were
replated on 100-mm dishes containing irradiated mouse embryonic
ﬁbroblasts (MEFs). The cells were maintained in IMDM with 10% FBS,
NEAA (1%), glutamine (1%), penicillin/streptomycin (1%), 50 μg/ml
ascorbic acid, and 4 ng/ml bFGF for 4 days. Thereafter, cells were
maintained in human embryonic stem cell medium (HES) containing
4 ng/ml of bFGF. The medium was replenished every 2–3 days forthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Generation and Characterization of CHOPHPS1. (A) Cre-mediated excision of the lentiviral vector in three clones of the CHOPHPS1 iPSC line. Cells from a non-excised lentiviral iPSC
linewere used as a positive control. (B) Validation of the HPS1mutation byDNA sequencing of HPS1 exon 15 and qPCRmeasurement of the HPS1 gene expression. (C) Karyotype analysis
of CHOPHPS1. (D) Flow cytometry proﬁles of surface markers on undifferentiated cells: SSEA3, SSEA4, TRA-1-60, and TRA-1-81. (E) Quantitative PCR of relative gene expression of
pluripotency genes compared to embryonic stem cells (H9 and CHB8), a control iPSC line (CHOPWT6), and the parental ﬁbroblast line (GM14609). (F) H&E staining of teratoma
sections identifying the three germ layers.
234 J.A. Maguire et al. / Stem Cell Research 16 (2016) 233–235
235J.A. Maguire et al. / Stem Cell Research 16 (2016) 233–2353 weeks until uniform colonies were generated. The iPSC colonies were
mechanically isolated and expanded on MEFs.
Cre-mediated STEMCCA excision
Transgene removal was performed as previously described (Somers
et al., 2010). Brieﬂy, iPSCs were transfected with 2 μg/well of pHAGE2-
Cre-IRES-PuroR plasmid DNA using Hela Monster transfection reagent
(Mirus, Madison, Wi) according to the manufacturer's instructions.
Cre-excised iPSC colonies were isolated by growth in puromycin
(1.2 μg/ml) selection medium 24 h post-transfection for 48 h. Genomic
DNAwas isolated using theDNeasy Blood& Tissue kit (Qiagen, Valencia,
CA) from each subclone after 2–3 weeks in culture and screened for
hSTEMCCA transgenes using the following primers: OCT4-Tg-F: 5′GGT
GCG CCA GTA AAG CAG ACA TTA AAC3′; KLF4-Tg-R: 5′CAG ACG CGA
ACG TGG AGA AAG A3′ and GAPDH-F: 5′GTG GAC CTG ACC TGC CGT
CT3′; GAPDH-R: 5′GGA GGA GTG GGT GTC GCT GT3′.
Mutation veriﬁcation
PCR ampliﬁcation was performed on genomic DNA isolated from
iPSCs using the referenced primer set: 5′GATGGTCCACAAAGGACGAG3′
and 5′GCGTGAAGGAAGTACGGGCC3′ (Oh et al., 1996). Products were
sequenced by the CHOP NAPCore facility. Expression of the mutated
HPS1 gene was shown by qPCR using the following primers: 5′ATAG
CAGAGGACACCCTCCAAACA3′ and 5′GGCAGTAGCTTTCCTTCACGTTGG3′.
Karyotype analysis
Chromosomal G-band analyses were performed in the Genomics
Core Laboratory (CHOP).
Flow cytometry analysis
Expression of pluripotencymarkerswas evaluated byﬂow cytometry
using the following antibodies: Alexa-Fluor®-647 α-human SSEA4
(1:400) and Tra-1-81 (1:200); Alexa-Fluor®-488 SSEA3 (1:200) and
Tra-1-60 (1:200) (BioLegend). Accutase-dissociated single cells were
analyzed using a FACSCanto ﬂow cytometer (BD Biosciences) and the
FlowJo software program (Tree Star, CA).RT–PCR and quantitative PCR
RNAwas isolated from the CHOPHPS1 iPSCs using the RNeasymicro
kit (Qiagen) according to themanufacturer's instructions. Reverse tran-
scriptionwas performed on total RNA (500 ng) using randomhexamers
and Superscript III Reverse Transcriptase (Life Technologies). RT–qPCR
was performed on a LightCycler-480II (Roche, IN). All experiments
were performed in triplicate using SYBR-Green qPCR supermix
(Roche) according to the manufacturer's instructions. Primers for
endogenous genes (DMNT3B, REX1, ABCG2, OCT4, NANOG, and SOX2)
were prepared as previously described (Mills et al., 2013). Humangeno-
mic DNA, diluted in 10-fold increments from 1 to 100 ng/μl, was used to
generate a standard curve to determine PCR efﬁciency and relative gene
expression compared to the housekeeping gene TBP (TATA Binding Box
Protein).
In vivo teratoma formation
CHOPHPS1 cells were cultured in feeder-free conditions and dissoci-
ated using trypsin. Single cells (~106) were resuspended in medium
containing growth-factor reduced matrigel (100 μl of 1:3 dilution in
IMDM) (Corning), and injected subcutaneously in the neck of NOD/
SCID mice. After 6–8 weeks, teratomas were excised and ﬁxed in 4%
phosphate-buffered formalin for 24 h. The ﬁxed samples were parafﬁn
embedded and hematoxylin and eosin (H&E) stained for histological
analysis. This work was approved by the IACUC committee at CHOP.
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